Neoplasia: An International Journal for Oncology Research (Feb 2015)

BUB1-bling over with Possibilities

  • Mary Helen Barcellos-Hoff

DOI
https://doi.org/10.1016/j.neo.2015.01.002
Journal volume & issue
Vol. 17, no. 2
pp. 153 – 154

Abstract

Read online

In a new report, Nyati et al. identified a previously undetected participant mediating both canonical signaling, i.e., TGF-β receptor kinase mediated, and non-canonical signaling, budding uninhibited by benzimidazole 1 (BUB1).